Evidence map›Paper›PMID 39264541›Full record

ArticleJournal of racial and ethnic health disparities2025

Vaccine Hesitancy at Nine Community Sites Across the United States, Early in COVID-19 Vaccine Rollout.

Aneeka Ratnayake, Julie H Hernandez, Jessica Justman, Jason E Farley, Yael Hirsch-Moverman, Ken Ho, Stockton Mayer, Abiodun Oluyomi, Magdalena E Sobieszczyk, Shobha Swaminathan and 4 more

Abstract read
In one paragraph

Article in Journal of racial and ethnic health disparities, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Aneeka RatnayakeSchool of Public Health and Tropical Medicine, Tulane University, 1440 Canal Street, Suite 2004, New Orleans, LA, 70112, USA.
Julie H HernandezSchool of Public Health and Tropical Medicine, Tulane University, 1440 Canal Street, Suite 2004, New Orleans, LA, 70112, USA.
Jessica JustmanICAP at Columbia University, Mailman School of Public Health, New York, USA.
Jason E FarleyCenter for Infectious Disease and Nursing Innovation, Johns Hopkins School of Nursing, Baltimore, USA.
Yael Hirsch-MovermanICAP at Columbia University, Mailman School of Public Health, New York, USA.
Ken HoDepartment of Medicine, University of Pittsburgh, Pittsburgh, USA.
Stockton MayerUniversity of Illinois College of Medicine, Chicago, USA.
Abiodun OluyomiBaylor College of Medicine, Houston, USA.
Magdalena E SobieszczykDivision of Infectious Diseases, Columbia University Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, Aaron Diamond AIDS Research Center, New York, USA.
Shobha SwaminathanRutgers New Jersey Medical School, Newark, USA.
Timothy SkallandFred Hutchinson Cancer Center, Seattle, USA.
Jean de Dieu TapsobaFred Hutchinson Cancer Center, Seattle, USA.
CoVPN 5002 Study Team
Patricia J KissingerSchool of Public Health and Tropical Medicine, Tulane University, 1440 Canal Street, Suite 2004, New Orleans, LA, 70112, USA. kissing@tulane.edu.

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI MYRON Scott COHEN, Sinead Delany-Moretlwe · 2011 to 2026
$779.5M
A new approach to controlling chlamydia transmission in young peopleR01HD086794 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI KISSINGER, PATRICIA J · 2016 to 2020
$2.9M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases UM1AI068619NIAID NIH HHS UM1 AI068619NICHD NIH HHS R01 HD086794
6 · The paper itself

Abstract

backgroundVaccine hesitancy has been a significant concern throughout the COVID-19 pandemic. Vaccine hesitancy can be attributed to lack of confidence in vaccines, complacency about the health threat, or lack of convenience of vaccination. To date, few studies have used methods designed to include populations underrepresented in research when identifying factors associated with vaccine hesitancy.

methodsBetween January and July 2021, potential participants were recruited from community venues selected through time-location sampling in 15 defined communities in the United States. Study staff administered a questionnaire on demographics, COVID-19 behaviors and attitudes, and vaccination status or intention to consenting individuals. Vaccine hesitancy was analyzed among those age 18 years and older from nine of the 15 sites and was defined as self-reported neutral, unlikely, or very unlikely vaccine intention. Logistic regression modeling, adjusted for site, identified factors associated with vaccine hesitancy.

resultsAmong 11,559 individuals, vaccine hesitancy by site ranged from 8.7 to 31.1%. Vaccine hesitancy was associated with being Black compared to White, being White compared to Asian, younger age, unstable housing, being unemployed, lower income, having a disability, providing care in home, not reporting inability to visit sick or elderly relatives during the pandemic, not reporting increased anxiety during the pandemic, and not spending more time with loved ones during the pandemic.

conclusionsIn these selected US communities, early in vaccine rollout, there were significant racial disparities in vaccine hesitancy. Additionally, individuals who were more marginalized due to their socioeconomic status were more likely to report vaccine hesitancy. Vaccine campaigns should make efforts to remove barriers to vaccination, by improving convenience.

Indexed as

COVID-19COVID-19 VaccinesVaccination HesitancyAdolescentAdultAgedFemaleHumansMaleMiddle AgedSurveys and QuestionnairesUnited StatesYoung AdultCOVID-19 VaccinesCommunity surveyCOVID-19HesitancyTime-location samplingUSVaccine

Identifiers

PMID39264541
PMCPMC12644162

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.